SQUAWK/NEWS
Theme
Menu
Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

4 results loaded, newest first. End of these results.

News 2026-09-28 11:04 UTC

Weekly Recap: inaxaplin Phase 2b UACR/UPCR cuts and AMPLITUDE enrollment

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported Phase 2b AMPLIFIED results where inaxaplin 45 mg reduced UACR ~42.7% and UPCR ~44.7% in modest-proteinuria patients with favorable tolerability, modest T2D effects, mild transient transaminase rises in ~13%, and shares jumped ~2.4% as AMPLI…

News 2026-06-23 10:15 UTC

VRT Rises 4%

Vertiv Holdings LLC shares close nearly 4% higher after a key trading signal